BioXcel Holdings, Inc.

BioXcel Holdings, Inc. is CEO & President +1 at BioXcel Therapeutics, Inc. (BTAI). They have made 2 open-market trades across 1 company since 2021, most recently 2024-06-05.

Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.

0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
BTAI	7,811,515	$576K

Shares reported on the most recent Form 4, priced at the 2024-06-06 close.

Grade by Ticker

BTAI

1 trade

Get alerted the next time BioXcel Holdings, Inc. files

Alerts when they file, saved screens, and the strategy books. 7-day free trial, no credit card required.

Follow BioXcel Holdings, Inc.

Sell Track Record

Filings2

Only 2 decision-sell filings — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.